Physician profile
Michael W Copeman
NPI 1710006879
$468.83
in general payments reported to CMS, 2019-2025
10 companies · $17.19 in 2025
The $17.19 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.41 · 2020: $50.23 · 2021: $58.83 · 2022: $90.35 · 2023: $80.11 · 2024: $107 · 2025: $17.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $245.58 | 2020-2025 | Bridion |
| Mallinckrodt Enterprises LLC | $65.41 | 2019 | |
| Teleflex LLC | $29.65 | 2024 | Urolift |
| Heron Therapeutics, INC. | $22.96 | 2021 | |
| Acacia Pharma INC | $20.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $19.49 | 2023 | Andexxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.63 | 2024 | Xifaxan |
| Mallinckrodt Hospital Products INC. | $16.52 | 2020 | |
| Draeger Medical Systems, INC | $16.46 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $15.13 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Copeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.